Jaya Indian Medicine Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.30 M
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Jaya Indian Medicine Pharmaceutical
Jaya Indian Medicine Pharmaceutical Private Limited (JIMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 May 2004 and has a history of 20 years and eight months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.30 M, as per Ministry of Corporate Affairs (MCA) records.
Puthumai Narayanan, Thirumalai, and Umadevi Jayaprakash serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233TN2004PTC053352
-
Company No.
053352
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 May 2004
-
Date of AGM
06 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Jaya Indian Medicine Pharmaceutical Private Limited offer?
Jaya Indian Medicine Pharmaceutical Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Siddha Medicines, Ayurvedic Churna and Goli, Herbal Piles Medicine, Herbal Capsules, Shatavari Capsule, Skin Care Oil, Talisadi Churna.
Who are the key members and board of directors at Jaya Indian Medicine Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puthumai Narayanan
|
Managing Director | 28-May-2004 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Thirumalai
|
Director | 28-May-2004 | Current |
|
Umadevi Jayaprakash
|
Director | 28-May-2004 | Current |
Financial Performance of Jaya Indian Medicine Pharmaceutical.
Jaya Indian Medicine Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaya Indian Medicine Pharmaceutical?
In 2017, Jaya Indian Medicine Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
The Chennai Sri Andal Dhana Sekara Saswatha Nidhi LimitedThirumalai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jaya Indian Medicine Pharmaceutical?
Unlock and access historical data on people associated with Jaya Indian Medicine Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaya Indian Medicine Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaya Indian Medicine Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.